HK1195791A1 - 種多肽 - Google Patents

種多肽

Info

Publication number
HK1195791A1
HK1195791A1 HK14109270.6A HK14109270A HK1195791A1 HK 1195791 A1 HK1195791 A1 HK 1195791A1 HK 14109270 A HK14109270 A HK 14109270A HK 1195791 A1 HK1195791 A1 HK 1195791A1
Authority
HK
Hong Kong
Prior art keywords
polypeptide
Prior art date
Application number
HK14109270.6A
Other languages
English (en)
Inventor
Johannes Loessner Martin
Eichenseher Fritz
Original Assignee
Micreos Human Health Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=44626456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HK1195791(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Micreos Human Health Bv filed Critical Micreos Human Health Bv
Publication of HK1195791A1 publication Critical patent/HK1195791A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2462—Lysozyme (3.2.1.17)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/305—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F)
    • C07K14/31—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Micrococcaceae (F) from Staphylococcus (G)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56938—Staphylococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Biophysics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Cell Biology (AREA)
  • Virology (AREA)
  • Food Science & Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
HK14109270.6A 2011-05-04 2014-09-12 種多肽 HK1195791A1 (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/NL2011/050307 WO2012150858A1 (en) 2011-05-04 2011-05-04 A polypeptide

Publications (1)

Publication Number Publication Date
HK1195791A1 true HK1195791A1 (zh) 2014-11-21

Family

ID=44626456

Family Applications (1)

Application Number Title Priority Date Filing Date
HK14109270.6A HK1195791A1 (zh) 2011-05-04 2014-09-12 種多肽

Country Status (15)

Country Link
US (2) US9382298B2 (zh)
EP (2) EP3085777B1 (zh)
JP (1) JP6261086B2 (zh)
KR (1) KR101911114B1 (zh)
CN (2) CN108192902A (zh)
AU (1) AU2011367262B2 (zh)
BR (1) BR112013028251B1 (zh)
CA (1) CA2834924C (zh)
DK (2) DK3085777T3 (zh)
ES (2) ES2768777T3 (zh)
HK (1) HK1195791A1 (zh)
IL (1) IL229247B (zh)
PL (2) PL3085777T3 (zh)
SG (1) SG194776A1 (zh)
WO (1) WO2012150858A1 (zh)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9206411B2 (en) * 2012-06-13 2015-12-08 The United States Of America, As Represented By The Secretary Of Agriculture Staphylococcal Phage2638A endolysin amidase domain is lytic for Staphylococcus aureus
EP3019185B1 (en) * 2013-07-11 2020-11-18 Micreos Human Health B.V. Combination treatment for atopic dermatitis
WO2015175774A1 (en) 2014-05-14 2015-11-19 Trustees Of Dartmouth College Deimmunized lysostaphin and methods of use
BR112017019413A2 (pt) 2015-03-12 2018-05-02 Micreos Human Health Bv combinação de agente bactericida com um agente alcalinizante lisossomotrópico para o tratamento de uma infecção bacteriana
EP3144387B1 (en) * 2015-09-15 2018-03-14 Micreos Human Health B.V. A novel endolysin polypeptide
US20200291373A1 (en) 2017-10-06 2020-09-17 Micreos Human Health B.V. Treatment of a Condition Associated with Infection with an Oncogenic Bacterium
EP3758738A4 (en) * 2018-02-26 2021-12-08 Contrafect Corporation MODIFIED PLYSS2-LYSINE AND USES THEREOF
JP7454211B2 (ja) 2020-01-20 2024-03-22 日本全薬工業株式会社 バクテリオファージ由来エンドライシン
JP2023518377A (ja) 2020-03-19 2023-05-01 マイクレオス ヒューマン ヘルス ビー．ブイ． 安定化された対象となるタンパク質
IL297430A (en) * 2020-04-20 2022-12-01 Micreos Human Health Bv Chimeric endolysin polypeptide
WO2023049243A1 (en) * 2021-09-22 2023-03-30 Biomedit, Llc Lysostaphin variants and methods of use thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NO2185699T3 (zh) * 2007-08-22 2018-04-21
ES2627321T3 (es) 2008-07-03 2017-07-27 The Rockefeller University Una lisina de bacteriófago quimérica con actividad contra bacterias estafilocócicas
AU2009273845B2 (en) * 2008-07-24 2016-02-04 The United State Of America, As Represented By The Secretary Of Agriculture Triple acting antimicrobials that are refractory to resistance development
EP2157100A1 (en) 2008-08-19 2010-02-24 Profos AG Artificial peptidoglycan lysing enzymes and peptidoglycan binding proteins
BR112012026880B1 (pt) * 2010-04-27 2021-03-16 Lysando Ag método para eliminação ou redução de um biofilme bacteriano, variante de endolisina ou variante de bacteriocina e seus usos
EP2702070B1 (en) * 2011-04-27 2015-09-30 Lysando AG New antimicrobial agents

Also Published As

Publication number Publication date
KR20140066976A (ko) 2014-06-03
EP3085777A1 (en) 2016-10-26
SG194776A1 (en) 2013-12-30
EP2705144A1 (en) 2014-03-12
BR112013028251B1 (pt) 2021-04-06
DK3085777T3 (da) 2020-02-03
CN103703127A (zh) 2014-04-02
JP6261086B2 (ja) 2018-01-17
IL229247B (en) 2019-03-31
IL229247A0 (en) 2014-01-30
AU2011367262A1 (en) 2013-11-21
CN108192902A (zh) 2018-06-22
US10174300B2 (en) 2019-01-08
US20160369255A1 (en) 2016-12-22
AU2011367262B2 (en) 2016-11-03
DK2705144T3 (da) 2016-09-05
EP2705144B1 (en) 2016-06-08
BR112013028251A2 (pt) 2017-01-17
KR101911114B1 (ko) 2018-10-23
JP2014519815A (ja) 2014-08-21
CA2834924A1 (en) 2012-11-08
US9382298B2 (en) 2016-07-05
WO2012150858A1 (en) 2012-11-08
ES2589784T3 (es) 2016-11-16
EP2705144B2 (en) 2019-08-28
DK2705144T4 (da) 2019-10-21
PL2705144T3 (pl) 2016-12-30
CA2834924C (en) 2022-08-16
US20140127168A1 (en) 2014-05-08
ES2589784T5 (es) 2020-04-21
ES2768777T3 (es) 2020-06-23
PL3085777T3 (pl) 2020-05-18
EP3085777B1 (en) 2019-11-06

Similar Documents

Publication Publication Date Title
ZA201309174B (en) Polypeptides
GB2583417B (en) A protein
HK1198734A1 (zh) 足部測量器
GB201113515D0 (en) A dressing
HK1195791A1 (zh) 種多肽
GB201111183D0 (en) Peptide
GB2497417B (en) A Former shoulder
EP2751136A4 (en) NATRIURETIC POLYPEPTIDE
GB201122102D0 (en) A canopy
GB201115910D0 (en) Peptides
HRP20171385T1 (hr) Kombinacije s peptidom s cikliziranom okosnicom
GB201106760D0 (en) A case
HK1207866A1 (zh) 含有主鏈環化肽的組合
HK1187628A1 (zh) 新型肽
GB2490717B (en) A rigger
EP2714717A4 (en) PHOENIXINPEPTIDE
GB201103117D0 (en) A structure
GB201112985D0 (en) Polypeptide
GB201112849D0 (en) Polypeptide
GB201106130D0 (en) Polypeptide
GB201122489D0 (en) A hand-glove
GB201122100D0 (en) A footgauge
AU340185S (en) A boilersuit
GB201113903D0 (en) A knee-walker
GB201112695D0 (en) A footgauge

Legal Events

Date Code Title Description
AM43 Amendment of standard patent following opposition or revocation proceedings in the designated patent office (acc. sect 43 patent ordinance)